528 related articles for article (PubMed ID: 25376453)
1. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
[TBL] [Abstract][Full Text] [Related]
2. Psychiatric disorders in women with fertility problems: results from a large Danish register-based cohort study.
Baldur-Felskov B; Kjaer SK; Albieri V; Steding-Jessen M; Kjaer T; Johansen C; Dalton SO; Jensen A
Hum Reprod; 2013 Mar; 28(3):683-90. PubMed ID: 23223399
[TBL] [Abstract][Full Text] [Related]
3. Mental disorders in childhood and young adulthood among children born to women with fertility problems.
Svahn MF; Hargreave M; Nielsen TS; Plessen KJ; Jensen SM; Kjaer SK; Jensen A
Hum Reprod; 2015 Sep; 30(9):2129-37. PubMed ID: 26202913
[TBL] [Abstract][Full Text] [Related]
4. Fertility drugs and incidence of thyroid cancer in a Danish nationwide cohort of 146 024 infertile women.
Lindquist S; Kjær SK; Albieri V; Frederiksen K; Hansen T; Nøhr B; Jensen A
Hum Reprod; 2022 Apr; 37(4):838-847. PubMed ID: 35020884
[TBL] [Abstract][Full Text] [Related]
5. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.
Rizzuto I; Behrens RF; Smith LA
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD008215. PubMed ID: 31207666
[TBL] [Abstract][Full Text] [Related]
6. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study.
Jensen A; Sharif H; Svare EI; Frederiksen K; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1400-7. PubMed ID: 17585058
[TBL] [Abstract][Full Text] [Related]
7. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study.
Hannibal CG; Jensen A; Sharif H; Kjaer SK
Hum Reprod; 2008 Feb; 23(2):451-6. PubMed ID: 18065402
[TBL] [Abstract][Full Text] [Related]
8. Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis.
Buis CC; van Leeuwen FE; Mooij TM; Burger CW;
Hum Reprod; 2013 Dec; 28(12):3358-69. PubMed ID: 24014607
[TBL] [Abstract][Full Text] [Related]
9. Melanoma risk after ovarian stimulation for in vitro fertilization.
Spaan M; van den Belt-Dusebout AW; Schaapveld M; Mooij TM; Burger CW; van Leeuwen FE;
Hum Reprod; 2015 May; 30(5):1216-28. PubMed ID: 25743782
[TBL] [Abstract][Full Text] [Related]
10. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.
Rizzuto I; Behrens RF; Smith LA
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD008215. PubMed ID: 23943232
[TBL] [Abstract][Full Text] [Related]
11. Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort.
Brinton LA; Westhoff CL; Scoccia B; Lamb EJ; Trabert B; Niwa S; Moghissi KS
Hum Reprod; 2013 Oct; 28(10):2813-21. PubMed ID: 23943795
[TBL] [Abstract][Full Text] [Related]
12. Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study.
Hannibal CG; Jensen A; Sharif H; Kjaer SK
Cancer Causes Control; 2008 Sep; 19(7):759-65. PubMed ID: 18340541
[TBL] [Abstract][Full Text] [Related]
13. Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study.
Jensen A; Sharif H; Kjaer SK
Am J Epidemiol; 2009 Dec; 170(11):1408-14. PubMed ID: 19884127
[TBL] [Abstract][Full Text] [Related]
14. Risk of juvenile idiopathic arthritis among children conceived after fertility treatment: a nationwide registry-based cohort study.
Sperling CD; Kjaer SK; Hargreave M; Jensen A
Hum Reprod; 2019 Jun; 34(6):1139-1145. PubMed ID: 30927428
[TBL] [Abstract][Full Text] [Related]
15. Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study.
Jensen A; Sharif H; Frederiksen K; Kjaer SK
BMJ; 2009 Feb; 338():b249. PubMed ID: 19196744
[TBL] [Abstract][Full Text] [Related]
16. Cumulative incidence rate of medical consultation for fecundity problems--analysis of a prevalent cohort using competing risks.
Duron S; Slama R; Ducot B; Bohet A; Sørensen DN; Keiding N; Moreau C; Bouyer J
Hum Reprod; 2013 Oct; 28(10):2872-9. PubMed ID: 23838160
[TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer risk after the use of ovulation-stimulating drugs.
Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
[TBL] [Abstract][Full Text] [Related]
18. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles.
Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
Hum Reprod; 2015 Mar; 30(3):684-91. PubMed ID: 25586787
[TBL] [Abstract][Full Text] [Related]
19. Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial.
Peeraer K; Debrock S; De Loecker P; Tomassetti C; Laenen A; Welkenhuysen M; Meeuwis L; Pelckmans S; Mol BW; Spiessens C; De Neubourg D; D'Hooghe TM
Hum Reprod; 2015 May; 30(5):1079-88. PubMed ID: 25788569
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for epithelial ovarian tumours of borderline malignancy.
Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
